Dameron Levest Jones

Array ( [id] => 8113781 [patent_doc_number] => 08158106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Particle immobilized coatings and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/261110 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 15844 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158106.pdf [firstpage_image] =>[orig_patent_app_number] => 10261110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787135 [patent_doc_number] => 20030138374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same' [patent_app_type] => new [patent_app_number] => 10/239154 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7580 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138374.pdf [firstpage_image] =>[orig_patent_app_number] => 10239154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876841 [patent_doc_number] => 07358343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Endohedral metallofullerene derivatives' [patent_app_type] => utility [patent_app_number] => 10/244747 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 2656 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358343.pdf [firstpage_image] =>[orig_patent_app_number] => 10244747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972403 [patent_doc_number] => 20050038113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease' [patent_app_type] => utility [patent_app_number] => 10/489770 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 15851 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038113.pdf [firstpage_image] =>[orig_patent_app_number] => 10489770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6707002 [patent_doc_number] => 20030153736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Labelled ascorbic acid derivatives' [patent_app_type] => new [patent_app_number] => 10/168714 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9096 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153736.pdf [firstpage_image] =>[orig_patent_app_number] => 10168714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846262 [patent_doc_number] => 20030165429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Method for measuring skin absorbability of a substance' [patent_app_type] => new [patent_app_number] => 10/238520 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8984 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165429.pdf [firstpage_image] =>[orig_patent_app_number] => 10238520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641455 [patent_doc_number] => 07122172 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-17 [patent_title] => 'Methods and compositions for targeted drug delivery' [patent_app_type] => utility [patent_app_number] => 10/238755 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12576 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122172.pdf [firstpage_image] =>[orig_patent_app_number] => 10238755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782485 [patent_doc_number] => 06991777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'Methods for in vivo evaluation of physiological conditions and/or organ or system function including methods to evaluate cardiopulmonary disorders such as chronic heart failure using polarized 129 Xe' [patent_app_type] => utility [patent_app_number] => 10/236156 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 13934 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/991/06991777.pdf [firstpage_image] =>[orig_patent_app_number] => 10236156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6747942 [patent_doc_number] => 20030042462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Magnetic fluids' [patent_app_type] => new [patent_app_number] => 10/232730 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4242 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20030042462.pdf [firstpage_image] =>[orig_patent_app_number] => 10232730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059752 [patent_doc_number] => 06852842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-08 [patent_title] => 'Methods for functional kidney imaging using small dendrimer contrast agents' [patent_app_type] => utility [patent_app_number] => 10/229316 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 27 [patent_no_of_words] => 7769 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852842.pdf [firstpage_image] =>[orig_patent_app_number] => 10229316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749831 [patent_doc_number] => 20030044351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Standardized compositions which facilitate swallowing in dysphagic subjects' [patent_app_type] => new [patent_app_number] => 10/227911 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5855 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044351.pdf [firstpage_image] =>[orig_patent_app_number] => 10227911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958626 [patent_doc_number] => 06953570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-11 [patent_title] => 'Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy' [patent_app_type] => utility [patent_app_number] => 10/225303 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 12978 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953570.pdf [firstpage_image] =>[orig_patent_app_number] => 10225303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817424 [patent_doc_number] => 20030068382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer' [patent_app_type] => new [patent_app_number] => 10/226288 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23608 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068382.pdf [firstpage_image] =>[orig_patent_app_number] => 10226288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735095 [patent_doc_number] => 20030012730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Preparation of radiolabelled haloaromatics via polymer-bound intermediates' [patent_app_type] => new [patent_app_number] => 10/224261 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5907 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012730.pdf [firstpage_image] =>[orig_patent_app_number] => 10224261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 481553 [patent_doc_number] => 07220401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Blood clot-targeted nanoparticles' [patent_app_type] => utility [patent_app_number] => 10/225024 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5310 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220401.pdf [firstpage_image] =>[orig_patent_app_number] => 10225024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379302 [patent_doc_number] => 20040028737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same' [patent_app_type] => new [patent_app_number] => 10/216315 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4572 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028737.pdf [firstpage_image] =>[orig_patent_app_number] => 10216315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073411 [patent_doc_number] => 06838074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent' [patent_app_type] => utility [patent_app_number] => 10/214429 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62271 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838074.pdf [firstpage_image] =>[orig_patent_app_number] => 10214429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979173 [patent_doc_number] => 06930177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'High-purity lanthanum isoproxide and a process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/214338 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5262 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930177.pdf [firstpage_image] =>[orig_patent_app_number] => 10214338 [rel_patent_id] =>[rel_patent_doc_number] =>)